Â¥
11.25
Nov 8
New Key Statistics Module, Z-Score and F-Score
SZSE:002873 Key Ratios
Market Cap ¥ M | 2,536.12 |
Enterprise Value ¥ M | 3,132.37 |
P/E(ttm) | 48.91 |
PE Ratio without NRI | 74.50 |
Forward PE Ratio | -- |
Price/Book | 2.47 |
Price/Sales | 3.18 |
Price/Free Cash Flow | 158.46 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.46 |
Revenue (TTM) ¥ M | 839.00 |
EPS (TTM) ¥ | 0.23 |
Beneish M-Score | -2.62 |
10-y EBITDA Growth Rate % | 7.70 |
5-y EBITDA Growth Rate % | 14.30 |
y-y EBITDA Growth Rate % | -34.80 |
EV-to-EBIT | 40.37 |
EV-to-EBITDA | 40.37 |
PEG | 5.21 |
Shares Outstanding M | 225.43 |
Net Margin (%) | 6.45 |
Operating Margin % | 7.12 |
Pre-tax Margin (%) | 6.88 |
Quick Ratio | 0.84 |
Current Ratio | 1.09 |
ROA % (ttm) | 2.78 |
ROE % (ttm) | 5.03 |
ROIC % (ttm) | 3.17 |
Dividend Yield % | 0.64 |
Altman Z-Score | 2.60 |
SZSE:002873 Number of Guru Trades
SZSE:002873 Volume of Guru Trades
Gurus Latest Trades with SZSE:002873
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002873 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guiyang Xintian Pharmaceutical Co Ltd Insider Transactions
No Available Data